Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed Oct 17, 2017 · 10-Q · 17 days after period end · 0001144204-17-052741
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$2.40M | -$1.61M | -$2.60M | -$2.42M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Oct 17, 2017 · 17 d after period end
